Our findings support that SMAD4 is an immune promoter that enhances the ability of CD8 + cytotoxic T cells to suppress tumors and impair CD15 + neutrophils from accelerating malignant progression in HPC. The gene discussed is SMAD4; the disease is hereditary chronic pancreatitis.